97 related articles for article (PubMed ID: 22112519)
1. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.
Morris AC; Beresford GW; Mooney MR; Boss JM
Mol Cell Biol; 2002 Jul; 22(13):4781-91. PubMed ID: 12052885
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.
Bhat KP; Truax AD; Greer SF
J Biol Chem; 2010 Aug; 285(34):25893-903. PubMed ID: 20538595
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2.
Taefehshokr N; Lac A; Vrieze AM; Dickson BH; Guo PN; Jung C; Blythe EN; Fink C; Aktar A; Dikeakos JD; Dekaban GA; Heit B
J Cell Sci; 2024 May; 137(10):. PubMed ID: 38682259
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide CIITA-binding profile identifies sequence preferences that dictate function versus recruitment.
Scharer CD; Choi NM; Barwick BG; Majumder P; Lohsen S; Boss JM
Nucleic Acids Res; 2015 Mar; 43(6):3128-42. PubMed ID: 25753668
[TBL] [Abstract][Full Text] [Related]
6. Tumor immunotherapy by converting tumor cells to MHC class II-positive, Ii protein-negative phenotype.
Lu X; Kallinteris NL; Li J; Wu S; Li Y; Jiang Z; Hillman GG; Gulfo JV; Humphreys RE; Xu M
Cancer Immunol Immunother; 2003 Oct; 52(10):592-8. PubMed ID: 12827305
[TBL] [Abstract][Full Text] [Related]
7. The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins.
León Machado JA; Steimle V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499042
[TBL] [Abstract][Full Text] [Related]
8. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.
Steidl C; Shah SP; Woolcock BW; Rui L; Kawahara M; Farinha P; Johnson NA; Zhao Y; Telenius A; Neriah SB; McPherson A; Meissner B; Okoye UC; Diepstra A; van den Berg A; Sun M; Leung G; Jones SJ; Connors JM; Huntsman DG; Savage KJ; Rimsza LM; Horsman DE; Staudt LM; Steidl U; Marra MA; Gascoyne RD
Nature; 2011 Mar; 471(7338):377-81. PubMed ID: 21368758
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the HIV-1 inhibitory factor human mannose receptor 1 by the myeloid-specific transcription factor PU.1.
Mallorson R; Miyagi E; Kao S; Sukegawa S; Saito H; Fabryova H; Morellatto Ruggieri L; Mediouni S; Valente ST; Strebel K
J Virol; 2024 Jan; 98(1):e0170223. PubMed ID: 38078733
[TBL] [Abstract][Full Text] [Related]
10. IL-27p28 specifically regulates MHC II expression in macrophages through CIITA.
Han Y; Zhang X; Wang Q; Cui X; Wang H; Zhang X; Wang Q; Ji J; Wang Y; Wang S; Zhang X; Xu H; Qiao M; Wu Z
Immunobiology; 2023 Nov; 228(6):152757. PubMed ID: 37944428
[TBL] [Abstract][Full Text] [Related]
11. Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF-PU.1-DPP4 Axis.
Wang L; Wang E; Prado Balcazar J; Wu Z; Xiang K; Wang Y; Huang Q; Negrete M; Chen KY; Li W; Fu Y; Dohlman A; Mines R; Zhang L; Kobayashi Y; Chen T; Shi G; Shen JP; Kopetz S; Tata PR; Moreno V; Gersbach C; Crawford G; Hsu D; Huang E; Bu P; Shen X
Adv Sci (Weinh); 2021 Oct; 8(19):e2004673. PubMed ID: 34378358
[TBL] [Abstract][Full Text] [Related]
12. RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma.
Jiao F; Li Z; He C; Xu W; Yang G; Liu T; Shen H; Cai J; Anastas JN; Mao Y; Yu Y; Lan F; Shi YG; Jones C; Xu Y; Baker SJ; Shi Y; Guo R
Sci Adv; 2020 Jul; 6(29):eaba2113. PubMed ID: 32832624
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses.
Chan KL; Gomez J; Cardinez C; Kumari N; Sparbier CE; Lam EYN; Yeung MM; Garciaz S; Kuzich JA; Ong DM; Brown FC; Chan YC; Vassiliadis D; Wainwright EN; Motazedian A; Gillespie A; Fennell KA; Lai J; House IG; Macpherson L; Ang CS; Dawson SJ; Beavis PA; Wei AH; Burr ML; Dawson MA
Cancer Cell; 2022 Oct; 40(10):1190-1206.e9. PubMed ID: 36179686
[TBL] [Abstract][Full Text] [Related]
14. Novel regulation of MHC class II function in B cells.
Matsuki Y; Ohmura-Hoshino M; Goto E; Aoki M; Mito-Yoshida M; Uematsu M; Hasegawa T; Koseki H; Ohara O; Nakayama M; Toyooka K; Matsuoka K; Hotta H; Yamamoto A; Ishido S
EMBO J; 2007 Feb; 26(3):846-54. PubMed ID: 17255932
[TBL] [Abstract][Full Text] [Related]
15. Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation.
Zhang J; Chen L; Xu Q; Zou Y; Sun F; Zhou Q; Luo X; Li Y; Chen C; Zhang S; Xiong F; Yang P; Liu S; Wang CY
Cell Death Dis; 2023 Nov; 14(11):737. PubMed ID: 37957143
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Genetically Diverse Macrophages Reveals Local and Domain-wide Mechanisms that Control Transcription Factor Binding and Function.
Link VM; Duttke SH; Chun HB; Holtman IR; Westin E; Hoeksema MA; Abe Y; Skola D; Romanoski CE; Tao J; Fonseca GJ; Troutman TD; Spann NJ; Strid T; Sakai M; Yu M; Hu R; Fang R; Metzler D; Ren B; Glass CK
Cell; 2018 Jun; 173(7):1796-1809.e17. PubMed ID: 29779944
[TBL] [Abstract][Full Text] [Related]
17. Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease.
Watt S; Vasquez L; Walter K; Mann AL; Kundu K; Chen L; Sims Y; Ecker S; Burden F; Farrow S; Farr B; Iotchkova V; Elding H; Mead D; Tardaguila M; Ponstingl H; Richardson D; Datta A; Flicek P; Clarke L; Downes K; Pastinen T; Fraser P; Frontini M; Javierre BM; Spivakov M; Soranzo N
Nat Commun; 2021 Apr; 12(1):2298. PubMed ID: 33863903
[TBL] [Abstract][Full Text] [Related]
18. Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells.
Miura R; Kasakura K; Nakano N; Hara M; Maeda K; Okumura K; Ogawa H; Yashiro T; Nishiyama C
PLoS One; 2016; 11(4):e0154094. PubMed ID: 27105023
[TBL] [Abstract][Full Text] [Related]
19. The gut lactic acid bacteria metabolite, 10-oxo-
Ando M; Nagata K; Takeshita R; Ito N; Noguchi S; Minamikawa N; Kodama N; Yamamoto A; Yashiro T; Hachisu M; Ichihara G; Kishino S; Yamamoto M; Ogawa J; Nishiyama C
Front Immunol; 2024; 15():1374425. PubMed ID: 38745644
[TBL] [Abstract][Full Text] [Related]
20. IL-33/ST2 Axis: A Potential Therapeutic Target in Neurodegenerative Diseases.
Jia Z; Guo M; Ge X; Chen F; Lei P
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
